Endowment Wealth Management, Inc.

Endowment

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1904477 APPLETON, WI

Position in RXRX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$45,801

New position

Shares Held

12,480

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#241

of 340 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Endowment Wealth Management, Inc. holds $369,618 across 4 Biotechnology names. RXRX ranks #3 (12.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	4,793	$225,462
2	HUMA	Humacyte, Inc.	105,418	$82,226
3	RXRX	Recursion Pharmaceuticals, Inc. This page	12,480	$45,801
4	CHRS	Coherus Oncology, Inc.	11,521	$16,129

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,801	12,480	—	Shares	Sole	2026-08-06
No filing history on record for this holder in this stock.